Pharma
Novel Target and Lead Packages for Diverse Indications
To facilitate the rapid progression of novel new drugs into clinical trials, our group focuses on new mechanistic studies and lead compound development necessary for the initial phases of drug development. We work on key facets of drug development that include mechanistic studies disease indications, clinical validations, structural analyses, and biomarkers for lead compound development.
| Image | Title | Info |
|---|---|---|
 | iMab : Technology for Targeting Cytosolic Proteins | |
 | Neo-pep : A Peptide of Human Origin for Skin and Scalp Health | |
 | Anti-tumorigenic GRS-derives Peptides : Novel Therapeutics for Kidney and Lung Cancer | |
 | Inhibitors of MRS : Novel Therapeutics for p16INK4a- Negative Cancers | |
 | Anti-metastatic KRS Inhibitors : Novel Therapeutics for Merastatic Triple-negative Breast Cancer | |
 | Novel LRS Inhibitors : Anti-tumor Agents for Colorectal Cancer | |
 | Anti-tumorigenic PRS Inhibitors : Novel Therapeutics for Pancreatic and Lung Cancer |
Tech
Devices, Kits and Instruments with Smart, Accurate, Fast, Economic Technologies
A key element of biotechnology development is the development of technology to increase the productivity of drug development. Among our product offerings, we have developed instruments can accurately analyze protein interactions, that facilitate antibody development, provide live imaging of disease detection and offer 3D culture analysis. We have additional capacity in new biochip products.
| Image | Title | Info |
|---|---|---|
 | IntraVital Microscopy (IVM) : In Vivo Cellular Efficacy Monitoring Platform for Drug Development | PDF Download |
 | Exosome Separation Platform : Ultracentrifuge-free-Size based Exosome Separation | PDF Download |
 | Nanobio Platform for Ultrafine Separation : Exosome Charting with Nanofluidic Systems | PDF Download |
 | Liposome Platforms for Tumor-Targeted Delivery of ARS Inhibitors | PDF Download |
 | Heterodimeric Fc Platform Technology for Bispecific Antibody | PDF Download |
 | Antibody & ELISA Technology : Validated, Short Term, Human Antibody Development | PDF Download |
 | 3D Cell Culture and Monitoring | PDF Download |
 | Targeted Sequencing with NGS for Low-cost and Precise : Detection of Genetic Disorder | PDF Download |
 | Diverse Chemical Libraries for Hit Identification | PDF Download |
 | Antibody Library Panning at Biocon : Solution for Human Antibody Generation | PDF Download |
 | Antibody Technology Platform at Biocon : Generation,Valication and Optimization | PDF Download |
 | 4D Micropillar / Microwell Chip | PDF Download |
 | 4D Cell Spotter | PDF Download |
 | 4D Cell Scanner | PDF Download |
Service
One Stop Solution for Experimental Needs
Biocon is committed to assimilating institutional infrastructure and knowhow so that we can effectively support and service Korean research groups or companies in new drug research. A key Biocon offering is a “One Stop Solution” that offers a broad selection of key drug development services, including the creation of novel proteins and antibodies, protein purification, dielectric, proteomics and 2D and 3D cell culture. We offer additional services in genetically modified animal models, drug potency checks of patient samples using mouse, bioanalysis, analysis of molecular binding using SPR. Finally, we can offer Biobank and inventory services.
| Image | Title | Info |
|---|---|---|
 | Protein Engineering | PDF Download |
 | Protein Modification | PDF Download |
 | Protein Purifiaction System | PDF Download |
 | Drug Efficiency Test using Patient | PDF Download |
 | Animal Model Service | PDF Download |
 | Drug Screening Test ub 3D Cell Culture System | PDF Download |
 | Pharge Display Panning Service | PDF Download |
 | Biobank Service | PDF Download |
 | Cell Imaging Service | PDF Download |
 | SPR Service | PDF Download |
 | Proteomics Service | PDF Download |
 | Drug Repositioning Service | PDF Download |
 | Project Landscaping System | PDF Download |